Ascendis Pharma AS (A71) — Cash Flow Quality Index
Latest as of March 2026:
-0.01x
Ascendis Pharma AS (A71) has a Cash Flow Quality Index of -0.01x as of March 2026. Operating cash flow of €-7.72 Million is below net income of €629.34 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Ascendis Pharma AS to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.01x
Operating CF / Net Income
Operating Cash Flow
€-7.72 Million
EUR
Net Income
€629.34 Million
EUR
Data as of
Mar 2026
Most recent filing
Annual Cash Flow Quality Index for Ascendis Pharma AS (None–None)
Year-by-year earnings quality comparison for Ascendis Pharma AS. For live market cap and the full company financial profile, see Ascendis Pharma AS (A71) total market value.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.